No abstract available
Keywords:
COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir.
Publication types
-
Letter
-
Observational Study
MeSH terms
-
Adenosine Monophosphate / adverse effects
-
Adenosine Monophosphate / analogs & derivatives*
-
Aged
-
Alanine / adverse effects
-
Alanine / analogs & derivatives*
-
Antiviral Agents / adverse effects*
-
Bradycardia / chemically induced*
-
Bradycardia / diagnosis
-
Bradycardia / epidemiology
-
Bradycardia / physiopathology
-
COVID-19 / diagnosis
-
COVID-19 / epidemiology
-
COVID-19 Drug Treatment*
-
Female
-
Heart Rate / drug effects*
-
Hospitalization
-
Humans
-
Incidence
-
Italy / epidemiology
-
Male
-
Middle Aged
-
Prospective Studies
-
Risk Assessment
-
Risk Factors
Substances
-
Antiviral Agents
-
remdesivir
-
Adenosine Monophosphate
-
Alanine